ā† Back to Search

Behavioural Intervention

Mobile Intervention for Alcohol and Marijuana Use (SAFERR Trial)

N/A
Recruiting
Led By Kristina Phillips, PhD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop an intervention for young adults who use marijuana and alcohol. The researchers will test different strategies to see which ones work best in reducing negative consequences and promoting protective behaviors. The study will

Who is the study for?
This trial is for young adults aged 18-30 in Hawaii who use marijuana and alcohol together, have experienced negative consequences from their use, and are confident they can follow protective strategies. They must have visited Kaiser Permanente Hawaii within the last year, live on O'ahu, and own a smartphone.
What is being tested?
The study tests different mobile interventions to help manage cravings and encourage safe behaviors when using alcohol and marijuana. Participants will be placed into one of eight groups with varying combinations of daily or triggered intervention strategies related to craving control and protective behavior support.
What are the potential side effects?
Since this is a behavioral intervention involving mobile prompts rather than medication, traditional physical side effects are not expected. However, participants may experience psychological discomfort or stress due to self-monitoring or changes in behavior.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Negative consequences associated with alcohol, marijuana, and simultaneous alcohol and marijuana (SAM) use
Protective behavioral strategies for alcohol
Protective behavioral strategies for marijuana
Secondary study objectives
Feasibility - acceptability of the intervention
Feasibility - goal attainment
Feasibility - intervention engagement
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

8Treatment groups
Experimental Treatment
Group I: Condition 8: No daily or trigger craving or PBSExperimental Treatment1 Intervention
EMA + Introduction Module + no other messages
Group II: Condition 7: Craving daily+Craving trigger+PBS daily+PBS triggerExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction delivered once daily, craving reduction trigger messages, PBS delivered once daily, and PBS trigger messages
Group III: Condition 6: Craving daily+Craving triggerExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction delivered once daily and craving reduction trigger messages
Group IV: Condition 5: PBS daily+ PBS triggerExperimental Treatment1 Intervention
EMA + Introduction Module + PBS delivered once daily and PBS trigger messages
Group V: Condition 4: Craving trigger+PBS triggerExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction trigger and PBS trigger messages
Group VI: Condition 3: Craving trigger+PBS dailyExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction trigger messages and PBS messages delivered once daily
Group VII: Condition 2: Craving daily+PBS triggerExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction messages delivered once daily and PBS trigger messages
Group VIII: Condition 1: Craving daily+PBS dailyExperimental Treatment1 Intervention
EMA + Introduction Module + Craving reduction and protective behavioral strategy (PBS) messages, each delivered once daily

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
552 Previous Clinical Trials
27,731,486 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,582 Previous Clinical Trials
3,326,914 Total Patients Enrolled
Kristina Phillips, PhDPrincipal InvestigatorKaiser Permanente Hawaii
~15 spots leftby Jan 2025